Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We synthesized three peptides, a D‐polyarginyl peptide (r8(FITC)), a Tat peptide (Tat(FITC)), and a control peptide (Cp(FITC)) and attached each to amino‐CLIO, a nanoparticle 30 nm in diameter. We then examined the effective permeability, Peff, of all six materials through CaCo‐2 monolayers. The transport of peptide–nanoparticles was characterized by a lag phase (0–8 h) and a steady‐state phase (9–27 h). The steady‐state Peff values for peptides were in the order r8(FITC)>Tat(FITC)=Cp(FITC). When r8(FITC) and Tat(FITC) peptides were attached to the nanoparticle, they conferred their propensity to traverse cell monolayers onto the nanoparticle, whereas Cp(FITC) did not. Thus, when the r8(FITC) peptide was attached to the amino‐CLIO nanoparticle, the resulting peptide–nanoparticle had a Peff similar to that of this poly‐d‐arginyl peptide alone. The Peff of r8(FITC)–CLIO (MW∼1000 kDa) was similar to that of mannitol (MW=182 Da), a poorly transported reference substance, with a far lower molecular weight. These results are the first to indicate that the modification of nanoparticles by attachment of membrane‐translocating sequence‐based peptides can alter nanoparticle transport through monolayers. This suggests that the surface modification of nanoparticles might be a general strategy for enhancing the permeability of drugs and that high‐permeability nanoparticle‐based therapeutics can be useful in selected pharmaceutical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Cited by
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Biological applications of gold nanoparticles
Sperling, R. A., Rivera Gil, P., Zhang, F., Zanella, M., & Parak, W. J. (2008) · Chemical Society Reviews · doi:10.1039/b712170a · Cited by 1,799
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
“Information was provided by studies performed on human in vitro models (Caco-2 cells for epithelial cells [81–86] and more recently human FAE model [87,88]), but clinical studies are still cruelly missing.”
MethodAzam, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29020 · Cited by 870
Limbach, L. K., Li, Y., Grass, R. N., Brunner, T. J., Hintermann, M. A., Muller, M., Gunther, D., & Stark, W. J. (2005) · Environmental Science & Technology · doi:10.1021/es051043o · Cited by 779
Detection and characterization of engineered nanoparticles in food and the environment
Tiede, K., Boxall, A. B. A., Tear, S. P., Lewis, J., David, H., & Hassellöv, M. (2008) · Food Additives & Contaminants: Part A · doi:10.1080/02652030802007553 · Cited by 737
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers
Torchilin, V. P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.008 · Cited by 449
Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives
Patel, L. N., Zaro, J. L., & Shen, W.-C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9303-7 · Cited by 425
Stabilization and functionalization of iron oxide nanoparticles for biomedical applications
Amstad, E., Textor, M., & Reimhult, E. (2011) · Nanoscale · doi:10.1039/c1nr10173k · Cited by 413
ANTIBACTERIAL ACTION OF ZINC OXIDE NANOPARTICLES AGAINST FOODBORNE PATHOGENS
TAYEL, A. A., EL‐TRAS, W. F., MOUSSA, S., EL‐BAZ, A. F., MAHROUS, H., SALEM, M. F., & BRIMER, L. (2011) · Journal of Food Safety · doi:10.1111/j.1745-4565.2010.00287.x · Cited by 361
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Gold nanoparticles in cancer therapy
Lim, Z.-Z. J., Li, J.-E. J., Ng, C.-T., Yung, L.-Y. L., & Bay, B.-H. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.82 · Cited by 314
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314
Nanoparticle formulations in pulmonary drug delivery
Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302
Poly(l-lysine)-Modified Iron Oxide Nanoparticles for Stem Cell Labeling
Babič, M., Horák, D., Trchová, M., Jendelová, P., Glogarová, K., Lesný, P., Herynek, V., Hájek, M., & Syková, E. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700410z · Cited by 291
Torchilin, V. P. (2008) · Peptide Science · doi:10.1002/bip.20989 · Cited by 283
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.010 · Cited by 265
Thubagere, A., & Reinhard, B. M. (2010) · ACS Nano · doi:10.1021/nn100389a · Cited by 163
Metadata
- Authors
- Koch, A. M., Reynolds, F., Merkle, H. P., Weissleder, R., & Josephson, L.
- Venue
- ChemBioChem
- Publisher
- Wiley
- Published
- 2005-01-28
- Volume
- 6
- Issue
- 2
- Pages
- 337-345
- ISSN
- 1439-4227 (ISSN-L)
- 1439-7633
- OpenAlex
- W2039433532
- Cited by
- 99
- References
- 2
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.